Ferric Citrate Tablets bulk supplier for pharma manufacturers

Ferric Citrate Tablets 210 mg, 500mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 210 mg, 500mg

Reference Brands: Auryxia(US), Ferrozan(EU)

Ferric Citrate Tablets are dual‑action nephrology agents that bind dietary phosphate and deliver oral iron to manage hyperphosphatemia and anemia in CKD patients. Marketed as Auryxia® (US) and Ferrozan® (EU), they simplify renal care and enhance patient compliance.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ferric Citrate Tablets? List it or send an offer →

Product Description:

Ferric Citrate Tablets are an essential nephrology therapy for managing hyperphosphatemia and anemia in chronic kidney disease (CKD). As a dual‑action phosphate binder and oral iron supplement, ferric citrate reduces serum phosphate levels while delivering bioavailable iron to support erythropoiesis. Marketed as Auryxia® in the US and Ferrozan® in the EU, these tablets streamline CKD care by replacing separate phosphate binders and iron supplements. Ideal for Pharma B2B distributors and hospital procurement, our bulk supply meets FDA and EMA standards, offering cost‑effective renal care solutions. Boost your portfolio with high‑quality Ferric Citrate Tablets for global renal therapy markets.

Ferric Citrate Tablets — third party manufacturing & bulk supply

Ferric Citrate Tablets 210 mg, 500mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ferric Citrate Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ferric Citrate Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ferric Citrate Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ferric Citrate Tablets is listed as Tablet in 210 mg, 500mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ferric Citrate Tablets is referenced against Auryxia(US), Ferrozan(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.